Difference between revisions of "IL21R-AS1"

From LncRNAWiki
Jump to: navigation, search
 
(9 intermediate revisions by the same user not shown)
Line 1: Line 1:
 
==Annotated Information==
 
==Annotated Information==
 +
[[File:Expression levels of CoroMarker,IL21R-AS1,BAT5,AC107016.1,and RP11-203B9.4 were quantified by qPCR in the PBMCs of CAD patients and control subjects.png|right|thumb|280px|'''Expression levels of CoroMarker,IL21R-AS1,BAT5,AC107016.1,and RP11-203B9.4 were quantified by qPCR in the PBMCs of CAD patients (n = 15) and control subjects (n = 15).''']]
 +
[[File:Expression levels of CoroMarker,IL21R-AS1,and BAT5 were quantified by qPCR in the PBMCs of CAD patients.png|right|thumb|280px|'''Expression levels of CoroMarker,IL21R-AS1, and BAT5 were quantified by qPCR in the PBMCs of CAD patients (n = 20) and control subjects (n = 20).''']]
 
===Approved Symbol===
 
===Approved Symbol===
 
IL21R-AS1 (IL21R antisense RNA 1)
 
IL21R-AS1 (IL21R antisense RNA 1)
 +
 
===Chromosome===
 
===Chromosome===
 
16p12.1
 
16p12.1
 +
 
===RefSeq ID===
 
===RefSeq ID===
 
NR_037158
 
NR_037158
===pubmed IDs===
+
 
26857419
 
 
===Expression===
 
===Expression===
qPCR analysis shows that IL21R-AS1 is 2.212-fold up-regulated in CAD (coronary artery disease) patients.
+
qPCR analysis shows that IL21R-AS1 is 2.212-fold up-regulated in CAD (coronary artery disease) patients.<ref name="ref1" />
[[File:Expression levels of CoroMarker, IL21R-AS1, BAT5, AC107016.1, and RP11-203B9.4 were quantified by qPCR in the PBMCs of CAD patients (n = 15) and control subjects (n = 15) (*P< 0.05 vs. control).jpg|right|thumb|400px|'''Expression levels of CoroMarker, IL21R-AS1, BAT5, AC107016.1, and RP11-203B9.4 were quantified by qPCR in the PBMCs of CAD patients (n = 15) and control subjects (n = 15) (*P< 0.05 vs. control).''']]
+
 
 
===Disease===
 
===Disease===
 
coronary artery disease. <ref name="ref1" />
 
coronary artery disease. <ref name="ref1" />
Line 20: Line 23:
 
==References==
 
==References==
 
<references>
 
<references>
<ref name="ref1">  
+
<ref name="ref1">Cai, Y., et al., Circulating 'lncRNA OTTHUMT00000387022' from monocytes as a novel biomarker for coronary artery disease. Cardiovasc Res, 2016. 112(3): p. 714-724.
 
</ref>(1)
 
</ref>(1)
 
</references>
 
</references>

Latest revision as of 08:11, 15 October 2017

Annotated Information

Expression levels of CoroMarker,IL21R-AS1,BAT5,AC107016.1,and RP11-203B9.4 were quantified by qPCR in the PBMCs of CAD patients (n = 15) and control subjects (n = 15).
Expression levels of CoroMarker,IL21R-AS1, and BAT5 were quantified by qPCR in the PBMCs of CAD patients (n = 20) and control subjects (n = 20).

Approved Symbol

IL21R-AS1 (IL21R antisense RNA 1)

Chromosome

16p12.1

RefSeq ID

NR_037158

Expression

qPCR analysis shows that IL21R-AS1 is 2.212-fold up-regulated in CAD (coronary artery disease) patients.[1]

Disease

coronary artery disease. [1]

Labs working on this lncRNA

  • Department of Cardiology, Daping Hospital, The Third Military Medical University, Chongqing, P.R. China.
  • Chongqing Institute of Cardiology, Chongqing, P.R. China.

References

  1. 1.0 1.1 Cai, Y., et al., Circulating 'lncRNA OTTHUMT00000387022' from monocytes as a novel biomarker for coronary artery disease. Cardiovasc Res, 2016. 112(3): p. 714-724.